Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0439 Transporter Info | ||||
Gene Name | SLC65A2 | ||||
Transporter Name | Niemann-Pick C1-like protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SREBF2 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of NPC1L1 gene in hyperlipidemia condition | [1] | ||||
TF Protein Name |
Sterol regulatory element-binding protein 2 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Atorvastatin | |||||
Studied Phenotype |
Hyperlipidemia [ICD11: 5C80] | |||||
Tissue |
Duodenum | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human hyperlipidemia duodenal cell isolates | |||||
Detailed Description |
Sterol regulatory element-binding protein 2 (SREBF2) has been reported to activate the transcription of NPC1L1 gene in hyperlipidemia condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
Transcriptional Phenomenon 2 |
Activation of NPC1L1 gene in gallstone disease condition | [2] | ||||
TF Protein Name |
Sterol regulatory element-binding protein 2 | Transcription Factor Info | ||||
Studied Phenotype |
Gallstone disease [ICD11: DC11.3] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human cholesterol gallstone disease liver cell isolates | |||||
Detailed Description |
Sterol regulatory element-binding protein 2 (SREBF2) has been reported to activate the transcription of NPC1L1 gene in gallstone disease condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
Transcriptional Phenomenon 3 |
Activation of NPC1L1 gene in colon cancer condition | [3] | ||||
TF Protein Name |
Sterol regulatory element-binding protein 2 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (Caco-2) | |||||
Detailed Description |
Sterol regulatory element-binding protein 2 (SREBF2) has been reported to activate the transcription of NPC1L1 gene in colon cancer condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of NPC1L1 gene in hyperlipidemia condition | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Atorvastatin | |||||
Studied Phenotype |
Hyperlipidemia [ICD11: 5C80] | |||||
Tissue |
Duodenum | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human hyperlipidemia duodenal cell isolates | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to activate the transcription of NPC1L1 gene in hyperlipidemia condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
NR1H2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of NPC1 gene in health condition | [4] | ||||
TF Protein Name |
Oxysterols receptor LXR-beta | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Blood | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human mature monocyte-derived macrophage isolates | |||||
Detailed Description |
Oxysterols receptor LXR-beta (NR1H2) has been reported to activate the transcription of NPC1 gene in health condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
NR1H3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of NPC1 gene in health condition | [4] | ||||
TF Protein Name |
Oxysterols receptor LXR-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Blood | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human mature monocyte-derived macrophage isolates | |||||
Detailed Description |
Oxysterols receptor LXR-alpha (NR1H3) has been reported to activate the transcription of NPC1 gene in health condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of NPC1L1 gene in gallstone disease condition | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Gallstone disease [ICD11: DC11.3] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human cholesterol gallstone disease liver cell isolates | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A) has been reported to activate the transcription of NPC1L1 gene in gallstone disease condition, which leads to an increased expression of the drug transporter Niemann-Pick C1-like protein 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.